Antiplatelets, statins, and cilostazol in peripheral artery disease: Medical therapy is the responsibility of the interventionalist

Vishesh Kumar, David Paul Slovut

Research output: Contribution to journalReview article

Abstract

Peripheral artery disease (PAD) is a common condition encountered in primary care and subspecialty clinics. Despite guidelines recommending antiplatelet agents, statins, and in some cases cilostazol, many patients with PAD are not receiving appropriate medications. Interventionalists who evaluate and treat these patients have a unique opportunity to prescribe appropriate cardioprotective medications, and to educate the primary care provider. In this article we will review guidelines for prescribing antiplatelet agents (aspirin and clopidogrel), statins, and cilostazol in patients with PAD; review evidence behind the guidelines; and present a "report card" of healthcare provider compliance with these guidelines. We will also describe some of the barriers that reduce clinician compliance with guidelines and present some strategies to overcome these barriers.

Original languageEnglish (US)
Pages (from-to)37-44
Number of pages8
JournalVascular Disease Management
Volume10
Issue number2
StatePublished - Feb 2013

Keywords

  • Medical treatment of peripheral artery disease
  • Peripheral artery disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Antiplatelets, statins, and cilostazol in peripheral artery disease: Medical therapy is the responsibility of the interventionalist'. Together they form a unique fingerprint.

  • Cite this